Isolated light chain deposition disease neuropathy in a patient with multiple myeloma. 2020

Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
Università Cattolica Del Sacro Cuore, Roma, Italia.

UI MeSH Term Description Entries
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013497 Sural Nerve A branch of the tibial nerve which supplies sensory innervation to parts of the lower leg and foot. Nerve, Sural,Nerves, Sural,Sural Nerves
D017772 Amyloid Neuropathies Disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. Familial, primary (nonfamilial), and secondary forms have been described. Some familial subtypes demonstrate an autosomal dominant pattern of inheritance. Clinical manifestations include sensory loss, mild weakness, autonomic dysfunction, and CARPAL TUNNEL SYNDROME. (Adams et al., Principles of Neurology, 6th ed, p1349) Neuropathies, Amyloid,Amyloid Neuropathy, Secondary,Amyloid Polyneuropathies,Amyloid Neuropathies, Secondary,Amyloid Neuropathy,Amyloid Polyneuropathy,Neuropathies, Secondary Amyloid,Neuropathy, Amyloid,Neuropathy, Secondary Amyloid,Polyneuropathies, Amyloid,Polyneuropathy, Amyloid,Secondary Amyloid Neuropathies,Secondary Amyloid Neuropathy

Related Publications

Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
August 1998, Italian journal of neurological sciences,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
January 2020, Indian journal of pathology & microbiology,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
January 1991, Acta haematologica,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
August 2021, International urology and nephrology,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
November 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
January 1999, Acta haematologica,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
December 1995, American journal of hematology,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
January 1993, Contributions to nephrology,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
January 1989, Clinical neuropathology,
Angela Romano, and Vittorio Riso, and Giulia Bisogni, and Andrea Di Paolantonio, and Elena Rossi, and Mario Sabatelli, and Serenella Servidei, and Marco Luigetti
May 2023, Blood,
Copied contents to your clipboard!